Publications by authors named "Christine E Horak"

26Publications

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.

Cell 2017 Nov 12;171(4):934-949.e16. Epub 2017 Oct 12.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00928674173112
Publisher Site
http://dx.doi.org/10.1016/j.cell.2017.09.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685550PMC
November 2017

Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?

Drugs 2016 Jun;76(9):925-45

Istituto Nazionale Tumori Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-016-0588-xDOI Listing
June 2016

Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma.

Clin Cancer Res 2015 Feb 18;21(4):712-20. Epub 2014 Dec 18.

Department of Cutaneous Oncology and Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, Florida. Department of Oncologic Sciences, University of South Florida, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2468DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620684PMC
February 2015

Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma.

J Clin Oncol 2013 Dec 21;31(34):4311-8. Epub 2013 Oct 21.

Jeffrey S. Weber, Ragini Reiney Kudchadkar, Bin Yu, Donna Gallenstein, Xiuhua Zhao, Alberto J. Martinez, Wenshi Wang, Geoffrey Gibney, Jodi Kroeger, Cabell Eysmans, Amod A. Sarnaik, and Y. Ann Chen, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and Christine E. Horak and H. David Inzunza, Bristol-Myers Squibb, Princeton, NJ.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.51.4802
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.51.4802DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837092PMC
December 2013

Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.

J Natl Cancer Inst 2012 Sep 21;104(17):1306-19. Epub 2012 Aug 21.

The Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djs319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611817PMC
September 2012

Altered gene and protein expression by Nm23-H1 in metastasis suppression.

Mol Cell Biochem 2009 Sep 5;329(1-2):141-8. Epub 2009 May 5.

Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, 37 Convent Drive, Room 1122, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11010-009-0124-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514412PMC
September 2009

The role of metastasis suppressor genes in metastatic dormancy.

APMIS 2008 Jul-Aug;116(7-8):586-601

Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0463.2008.01213.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508681PMC
November 2008

Clinical-translational approaches to the Nm23-H1 metastasis suppressor.

Clin Cancer Res 2008 Aug;14(16):5006-12

Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, 37 Convent Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-0238DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730725PMC
August 2008

Alterations in Gemin5 expression contribute to alternative mRNA splicing patterns and tumor cell motility.

Cancer Res 2008 Feb;68(3):639-44

Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-2632DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678556PMC
February 2008

Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.

Cancer Res 2007 Dec;67(24):11751-9

Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-3175DOI Listing
December 2007

Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth.

Clin Exp Metastasis 2008 5;25(2):131-8. Epub 2007 Dec 5.

Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NCI/NIH, 37 Convent Dr., Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10585-007-9128-0DOI Listing
June 2008

Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.

Cancer Res 2007 Aug;67(15):7238-46

Women's Cancer Section, Laboratory of Molecular Pharmacology, National Cancer Institute/NIH, 37 Convent Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-0962DOI Listing
August 2007

Translational approaches using metastasis suppressor genes.

J Bioenerg Biomembr 2006 Aug;38(3-4):151-61

Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Building 37, Room 1122, NIH, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10863-006-9039-9DOI Listing
August 2006

Metastasis gets site specific.

Cancer Cell 2005 Aug;8(2):93-5

Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Building 37, Room 1122, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2005.07.013DOI Listing
August 2005

ExpressYourself: A modular platform for processing and visualizing microarray data.

Nucleic Acids Res 2003 Jul;31(13):3477-82

Department of Molecular Biophysics and Biochemistry, Yale University, 266 Whitney Avenue, PO Box 208114, New Haven CT 06520-8114, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC169034PMC
http://dx.doi.org/10.1093/nar/gkg628DOI Listing
July 2003

Global analysis of gene expression in yeast.

Funct Integr Genomics 2002 Sep 10;2(4-5):171-80. Epub 2002 Jul 10.

Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10142-002-0065-3DOI Listing
September 2002

ChIP-chip: a genomic approach for identifying transcription factor binding sites.

Methods Enzymol 2002 ;350:469-83

Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0076-6879(02)50979-4DOI Listing
August 2002

GATA-1 binding sites mapped in the beta-globin locus by using mammalian chIp-chip analysis.

Proc Natl Acad Sci U S A 2002 Mar 26;99(5):2924-9. Epub 2002 Feb 26.

Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.052706999DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC122449PMC
March 2002